BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17340553)

  • 1. [A nursing experience in a patient with antipsychotics-induced overweight].
    Su MC; Hsu CC; Lin YR; Tzeng WC
    Hu Li Za Zhi; 2007 Feb; 54(1):90-6. PubMed ID: 17340553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].
    Cordes J; Sinha-Röder A; Kahl KG; Malevani J; Thuenker J; Lange-Asschenfeldt C; Hauner H; Agelink MW; Klimke A
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):703-14. PubMed ID: 18924059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of antipsychotics to medication regimens during schizophrenic inpatient care.
    Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nursing care for an organophosphate poisoning suicidal woman].
    Lin HW; Chou HL
    Hu Li Za Zhi; 2007 Oct; 54(5):104-10. PubMed ID: 17935054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nursing Experience of Using Mirror Visual Feedback for a Schizophrenia Patient With Visual Hallucinations].
    Lan SL; Chen YC; Chang HJ
    Hu Li Za Zhi; 2018 Jun; 65(3):103-111. PubMed ID: 29790145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COPE Healthy Lifestyles TEEN program: feasibility, preliminary efficacy, & lessons learned from an after school group intervention with overweight adolescents.
    Melnyk BM; Small L; Morrison-Beedy D; Strasser A; Spath L; Kreipe R; Crean H; Jacobson D; Kelly S; O'Haver J
    J Pediatr Health Care; 2007; 21(5):315-22. PubMed ID: 17825729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Providing care to an elephant leg patient: a nurse's experience].
    Chen TH; Wang CY; Chang ML
    Hu Li Za Zhi; 2010 Apr; 57(2 Suppl):S99-103. PubMed ID: 20405406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of augmentatory repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: randomized controlled study.
    Bagati D; Nizamie SH; Prakash R
    Aust N Z J Psychiatry; 2009 Apr; 43(4):386-92. PubMed ID: 19296295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Challenges in nutrition-based treatment for weight control in adolescents suffering from schizophrenia].
    Shani M; Levi M; Zalsman G
    Harefuah; 2008 Nov; 147(11):901-5, 939. PubMed ID: 19264012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
    Leucht S; Kissling W; Davis JM
    Psychol Med; 2009 Oct; 39(10):1591-602. PubMed ID: 19335931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication.
    Jones M; Jones A
    J Psychiatr Ment Health Nurs; 2007 Jun; 14(4):418-23. PubMed ID: 17517033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.